Gene · 94
Papers4,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hereditary Hemorrhagic Telangiectasia: Diagnosis and Management. | J Clin Med | 2022 | 36012936 | PubTator, text mining | PubMed |
| Endometrial Cancer in Aspect of Forkhead Box Protein Contribution. | Int J Environ Res Public Health | 2022 | 36012038 | PubTator, text mining | PubMed |
| Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis. | PLoS One | 2022 | 36006934 | PubTator, text mining | PubMed |
| Heteronemin and Tetrac Induce Anti-Proliferation by Blocking EGFR-Mediated Signaling in Colorectal Cancer Cells. | Mar Drugs | 2022 | 36005485 | PubTator, text mining | PubMed |
| KLF4 recruits SWI/SNF to increase chromatin accessibility and reprogram the endothelial enhancer landscape under laminar shear stress. | Nat Commun | 2022 | 35999210 | PubTator, text mining | PubMed |
| A human model of arteriovenous malformation (AVM)-on-a-chip reproduces key disease hallmarks and enables drug testing in perfused human vessel networks. | Biomaterials | 2022 | 35999080 | PubTator, text mining | PubMed |
| Potential utility of miRNAs for liquid biopsy in breast cancer. | Front Oncol | 2022 | 35992785 | PubTator, text mining | PubMed |
| Gray zone lymphoma effectively treated with cyclophosphamide, doxorubicin, vincristine, prednisolone, and rituximab chemotherapy: A case report. | World J Clin Cases | 2022 | 35979119 | PubTator, text mining | PubMed |
| An in vitro study on the effect of bevacizumab on endothelial cell proliferation and VEGF concentration level in patients with hereditary hemorrhagic telangiectasia. | Exp Ther Med | 2022 | 35978926 | PubTator, text mining | PubMed |
| TGF-β Superfamily Signaling in the Eye: Implications for Ocular Pathologies. | Cells | 2022 | 35954181 | PubTator, text mining | PubMed |
| Pivotal models and biomarkers related to the prognosis of breast cancer based on the immune cell interaction network. | Sci Rep | 2022 | 35953532 | PubTator, text mining | PubMed |
| Clinical staging and genetic profiling of Korean patients with primary lymphedema using targeted gene sequencing. | Sci Rep | 2022 | 35948757 | PubTator, text mining | PubMed |
| Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension. | J Smooth Muscle Res | 2022 | 35944979 | PubTator, text mining | PubMed |
| Screening and identification of immune-related genes for immunotherapy and prognostic assessment in colorectal cancer patients. | BMC Med Genomics | 2022 | 35941638 | PubTator, text mining | PubMed |
| Survival Outcomes and Predictors for Recurrence of Surgically Treated Brain Metastasis From Non-Small Cell Lung Cancer. | Brain Tumor Res Treat | 2022 | 35929115 | PubTator, text mining | PubMed |
| The molecular mechanisms of CTHRC1 in gastric cancer by integrating TCGA, GEO and GSA datasets. | Front Genet | 2022 | 35928443 | PubTator, text mining | PubMed |
| Cardiac and Hemodynamic Manifestations of Hereditary Hemorrhagic Telangiectasia. | Int J Angiol | 2022 | 35923582 | PubTator, text mining | PubMed |
| Treatment pattern and outcomes in de novo T790M-mutated non-small cell lung cancer. | Ecancermedicalscience | 2022 | 35919239 | PubTator, text mining | PubMed |
| Developmental modeling of hepatogenesis using obese iPSCs-hepatocyte differentiation uncovers pathological features. | Cell Death Dis | 2022 | 35915082 | PubTator, text mining | PubMed |
| Genetics of hyperuricemia and gout: Insights from recent genome-wide association studies and Mendelian randomization studies. | Tzu Chi Med J | 2022 | 35912057 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94/papers?page=35